Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in Mice
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 12 (3) , 1166-1178
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (WA-4610/1-1, ZIA BC 011345, ZO1 BC010870)
- National Institutes of Health (WA-4610/1-1, ZIA BC 011345, ZO1 BC010870)
- National Cancer Institute (WA-4610/1-1, ZIA BC 011345, ZO1 BC010870)
This publication has 38 references indexed in Scilit:
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJournal of Hepatology, 2014
- CholangiocarcinomaThe Lancet, 2014
- From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices PipelineCurrent Protocols in Bioinformatics, 2013
- Cholangiocarcinomas can originate from hepatocytes in miceJournal of Clinical Investigation, 2012
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- A flexible R package for nonnegative matrix factorizationBMC Bioinformatics, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based StudyAnnals of Surgical Oncology, 2007
- Metagenes and molecular pattern discovery using matrix factorizationProceedings of the National Academy of Sciences of the United States of America, 2004
- Biliary Tract CancersNew England Journal of Medicine, 1999